Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease

A. Brachat, E. Feist, F. Behrens, N. Blank, N. R. Nirmala, C. Specker, M. Witt, J. Zernicke, A. Martini, G. Junge

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalPediatric Rheumatology
Publication statusAccepted/In press - Sept 28 2015

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this